UK report recommends medical trials of cannabisBMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7169.1337a (Published 14 November 1998) Cite this as: BMJ 1998;317:1337
- Hugh Matthews
Britain's House of Lords Science and Technology Committee recommended in a report published this week that cannabis should be reclassified as a schedule 2 drug, allowing research and prescription by doctors on a named patient basis.
The report called for clinical trials of cannabis in the treatment of multiple sclerosis and chronic pain but recommended that doctors should …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial